New Market Research Report: VistaGen Therapeutics , Inc. (VSTA) - Product Pipeline Analysis, 2014 Update
VistaGen Therapeutics, Inc. (VistaGen) is a biopharmaceutical company. The company develops stem cell technology platform based on the controlled differentiation of human pluripotent stem cells. Its products include Cardiosafe 3D, Liversafe 3D, and av-101. VistaGen's stem cell technology is used to create novel bioassay systems for predictive toxicology, drug discovery, drug rescue, and cell therapy applications. The company's cardiosafe 3D product is a novel bioassay system that uses mature human heart cells derived from pluripotent stem cells to screen for...
View full press release